## **Core Concept**
Montelukast is a type of medication used in the management of respiratory conditions, specifically targeting the cysteinyl leukotriene receptor. It plays a role in the inflammatory process associated with asthma and allergic rhinitis. Understanding its mechanism of action is crucial for its clinical application.

## **Why the Correct Answer is Right**
Montelukast works by selectively antagonizing the cysteinyl leukotriene receptor (CysLT1 receptor). Leukotrienes are pro-inflammatory mediators produced in the body, involved in the pathogenesis of asthma and allergic rhinitis. By blocking the action of these leukotrienes at the CysLT1 receptor, montelukast reduces inflammation, airway constriction, and mucus production. This mechanism makes it an effective option for the long-term management of asthma and for alleviating symptoms of allergic rhinitis.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Incorrect because montelukast's action is more specific than a general anti-inflammatory effect; it targets a specific receptor.
- **Option B:** Incorrect as montelukast is not a corticosteroid; it does not work by influencing gene expression in the way corticosteroids do.
- **Option C:** Incorrect because, although montelukast affects the respiratory system, it is not a bronchodilator; it does not cause relaxation of bronchial smooth muscles directly.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that montelukast is often used as an add-on therapy in patients with mild to moderate asthma who are not adequately controlled on inhaled corticosteroids alone. It is also noteworthy for its once-daily dosing, making it convenient for patients.

## **Correct Answer:** D. Leukotriene receptor antagonist.